Urinary-tract infections (UTIs) are common medical condition on pregnant women that could lead to severe consequences for both the mother and the fœtus.
A prospective, descriptive and analytical study was conducted from February to May 2018, at the laboratory of UHC PZaGa, in collaboration with the service of prenatal care (PNC) of the Integrated Health Center (IHC) of Mahabibo.
In whole, 210 pregnant women, aged from 15 to 44 were investigated. The average age was 24,9. The UTIs prevalence rate was 6,7% (n=14). Among risk factors, only diabetes had a statistical significance (p<0,001). After clinical findings, asymptomatic forms were predominant with 57,1% (n=8). Among the identified strains, enterobacteriaceae and staphylococcus represented 78,6%, n=11). The enterobacteriaceae were predominant with 35,7% Escherichia coli, 21,4% Klebsiella pneumoniae and 21,4% for unidentified strains. Three cases were attributed to Staphylococcus which comprise one isolate of Staphylococcus aureus (7,1%) and 2 negative-coagulase Staphylococci (14,3%). These enterobacteriaceae were resistant to Amoxicillin (70%), to the combination Amoxicillin-Clavulanate (70%), Ceftriaxone (10%), Ciprofloxacin (30%) and to Gentamicine (70%). One strain of K. pneumoniae was assigned with multidrug resistance and producer of extended spectrum beta-lactamase.
The UTIs prevalence on pregnant women is not minor though it does not represent a concern in epidemiological view. Therapy is advised and must be adapted to the clinical case.